Taipei, Taiwan (Merxwire) - The China Financial Development (CDF) and its subsidiaries, including CBID Capital, its private equity arm chaired by Angelo Koo, has posted healthy financial results for the first half of 2022 despite challenges brought on by the COVID-19 pandemic and geopolitical conflicts that have shifted the economic landscape of various markets.

Other subsidiaries of CDF such as China Life, have been high-performers and covered some of the losses encountered from unexpected current events and fluctuations. CDF foresaw the market potential and moved quickly to acquire China Life earlier this year, becoming a shining heavyweight of after-tax profits. To put things into perspective, CDF alone achieved an NT$9.67 million after-tax profits in the first quarter of 2022, while China Life saw an after-tax net income of NT$88.40 billion. China Life's embedded value rose to NT$402.5 billion as of the end of last year, up 12.6 percent from a year earlier, following the increase of its adjusted net worth and the value of in force. Efforts by CDF to diversify and continually push for expansion has paid off thus far, long-term results seem strong but are yet to be seen.

While CBID Capital's June results have been affected by fluctuation in the valuation of its investment portfolios, the company is making plans to expand its asset management services such as supporting start-ups in Japan.

Media Contact Information:
Company: Jet-Go Consulting
Contact person: Alvin Yang
Tel: +886-2-2370-8000 #2110